GUCCIONE, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 5.822
AS - Asia 3.128
EU - Europa 2.919
SA - Sud America 504
AF - Africa 257
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 12.645
Nazione #
US - Stati Uniti d'America 5.578
SG - Singapore 1.659
RU - Federazione Russa 909
CN - Cina 829
IE - Irlanda 513
UA - Ucraina 474
BR - Brasile 401
IT - Italia 384
VN - Vietnam 227
CA - Canada 194
FR - Francia 158
DE - Germania 134
KR - Corea 86
SE - Svezia 85
CI - Costa d'Avorio 75
NG - Nigeria 68
FI - Finlandia 66
GB - Regno Unito 66
IN - India 57
SN - Senegal 49
AR - Argentina 41
BD - Bangladesh 35
MX - Messico 33
IQ - Iraq 32
HK - Hong Kong 27
TR - Turchia 22
NL - Olanda 21
UZ - Uzbekistan 21
PL - Polonia 20
CH - Svizzera 19
JP - Giappone 19
EC - Ecuador 18
ID - Indonesia 18
ZA - Sudafrica 18
PK - Pakistan 15
IR - Iran 13
VE - Venezuela 13
AT - Austria 12
BE - Belgio 12
ES - Italia 10
EU - Europa 10
MA - Marocco 10
CO - Colombia 9
IL - Israele 8
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
BJ - Benin 6
CL - Cile 6
CZ - Repubblica Ceca 5
GR - Grecia 5
HN - Honduras 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
LT - Lituania 5
PH - Filippine 5
SA - Arabia Saudita 5
AU - Australia 4
DZ - Algeria 4
KG - Kirghizistan 4
MD - Moldavia 4
NP - Nepal 4
PE - Perù 4
TN - Tunisia 4
AZ - Azerbaigian 3
ET - Etiopia 3
HU - Ungheria 3
MY - Malesia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
TH - Thailandia 2
BH - Bahrain 1
BM - Bermuda 1
CU - Cuba 1
DK - Danimarca 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 12.638
Città #
Singapore 933
Dallas 892
Santa Clara 666
Chandler 520
Dublin 512
Jacksonville 499
San Jose 361
Moscow 341
Chicago 265
Ashburn 257
Boardman 228
Nanjing 158
Lawrence 145
Cambridge 144
Andover 141
Toronto 137
Lauterbourg 131
Civitanova Marche 106
Hefei 103
Beijing 94
Catania 93
Munich 87
Seoul 85
Ho Chi Minh City 84
Los Angeles 81
San Mateo 80
Houston 79
Abidjan 75
Des Moines 69
Helsinki 59
Shenyang 55
Wilmington 53
Hanoi 52
Dakar 49
Nanchang 49
Hebei 43
Saint Petersburg 40
São Paulo 35
Council Bluffs 34
Abuja 33
Lagos 30
Tianjin 30
Ottawa 27
Buffalo 25
Jiaxing 25
New York 24
Hong Kong 23
Changsha 22
Orem 20
Atlanta 17
Tokyo 17
Brooklyn 16
Montreal 16
Denver 15
Naples 15
Rio de Janeiro 15
Bremen 14
Da Nang 14
Johannesburg 14
Baghdad 13
Seattle 13
Amsterdam 12
Brussels 12
Pune 12
Warsaw 12
Augusta 11
Bari 11
Belo Horizonte 11
Haiphong 11
Rome 11
Columbus 10
Norwalk 10
Phoenix 10
Redondo Beach 10
The Dalles 10
Ardabil 9
Curitiba 9
Mexico City 9
Poplar 9
Stockholm 9
Washington 9
Barlassina 8
Frankfurt am Main 8
Leawood 8
London 8
Mumbai 8
Tashkent 8
Ankara 7
Brasília 7
Campinas 7
Chennai 7
Kunming 7
Quito 7
San Francisco 7
Zhengzhou 7
Ann Arbor 6
Asunción 6
Boston 6
Caracas 6
Charlotte 6
Totale 8.614
Nome #
Application of PARM to constructing and comparing 5-HT1A and alfa1 receptor models 236
Pharmacological properties and biochemical mechanisms of MOR ligands might be due to different binding poses. MD Studies 151
Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling 150
Correlating in Vitro Target-Oriented Screening and Docking: Inhibition of Matrix Metalloproteinases Activities by Flavonoids 146
A 3D QSAR study of Monoamino Oxidase B inhibitors, using the chemical function based pharmacophore generation approach 140
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 132
Quantum chemical and molecular dynamics studies of MUC-1 calix[4,8]arene scaffold based anti-cancer vaccine candidates 132
5-HT1A receptors mapping by conformational analysis (2D NOESY/MM) and "tree way modelling" (HASL, CoMFA, PARM) 131
4 Methyl-2-[N-(3,4-methylenedioxy-benzylidene)hydrazino]thiazole and its reduction product, 4-methyl-2-[N-(3,4-methylenedioxybenzylidene)-hydrazono]-4,5-dihydrothiazole 131
Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors 127
Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy 123
A new procedure for the synthesis of 4H-pyrazolo[1,5-c][1,3,5]thiadiazine-4-thiones 122
An efficient procedure for the synthesis of Pyrazolo[3,4-d] [1,3] Thiazin-4-ones 119
16. Towards a complete picture of chiral discrimination processes by C9 carbamate derivatives of dihydroquinine: interaction mechanisms of diastereoisomeric 9-O-[(S)- or (R)-1-(1-naphthyl)ethylcarbamate]dihydroquinine and the two enantiomers of N-(3,5-dinitrobenzoyl)alanine methyl ester 119
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 116
Alkylation of non-electron rich nitrogen heterocycles by alkyl orthoformates: quantum chemistry calculations 115
In-silico design and biological investigations of Diabetic Neuropathy modulators: could MOR become a focal mediator for this pathology? 115
Application of Parm to constructing and comparing 5-HT1A and alfa1 receptor models 114
Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity 113
5HT1a Receptor Binding Affinities of a Series of Serotonin Transporter (SERT) Inhibitors and Related Thermodynamic Insights 113
3D-QSAR Using ”Multiconformer” Alignment: The Use of HASL in the Analysis of 5-HT1A Thienopyrimidinone Ligands 111
5-HT1A receptor binding analysis of thienopyrimidinones partial agonists: a paradigm breaking study regarding the pharmacophoric leadership of the protonated piperazine ring in GPCR ligands 111
Molecular modeling studies on mu opioid receptor of agonists and antagonists, endogenous and exogenous, ligands 110
Binding of imidazline ligands to the active site of purified MAO A 108
Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: Synthesis, biological evaluation, and docking studies 108
5-HT1A receptors mapping by conformational analysis (2D NOESY/MM) and ”three way modelling” (HASL, CoMFA, PARM) 107
An Alternative Method for 3D-QSAR and the Alignment of Molecular Structures: BiS (Biological Substrate Search) 106
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase 106
A field-based disparity analysis of new 1,2,5- oxadiazole derivatives endowed with antiproliferative activity 105
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 104
Imidazole Derivatives as Heme Oxygenase-1 Inhibitors 103
Building a model of interaction at the NK-2 receptors: polycondensed heterocycles containing the pyrimidoindole skeleton 103
TCP-FA4: A derivative of tranylcypromine showing improved blood-brain permeability 102
Spectroscopic Investigation and Molecular Modeling on Porphyrin/PAMAM Supramolecular Adduct 101
Potential of Aryl-urea-Benzofuranylthiazoles hybrids as multitasking agents in Alzheimer’s disease 101
Synthesis and pharmacological evaluation of benzothieno and [1]pyridothieno [2,3-d]triazole derivatives as antagonists at NK-1 receptors 101
ML10302 101
Molecular modelling of a novel class of N5-methanesulfonamide dihydrothienopyrimidinoners as potential dual COX-2 inhibitor/ 100
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine 99
Interaction of natural flavonoid eriocitrin with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin: an NMR and molecular dynamics investigation 99
Pyrimido[5,4-b] Indole derivatives. 1. A new class of potent and selective alpha-1 adrenoceptor ligands 98
Parameters for irreversible inactivation of monoamine oxidase 98
Sensory Analysis on Red Wines: Discrimination by Adaptive Fuzzy Partition (AFP) 97
Homology-based modeling of rhodopsin-like family members in the inactive state: structural analysis and deduction of tips for modeling and optimization. 97
Application of PARM to constructing and comparing 5-HT1A and alpha1 receptor models 97
Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 (R) and RL100 (R) 96
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 96
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models 95
Stereoretentive Chlorination of Cyclic Alcohols Catalyzed by Titanium (IV) Tetrachloride: Evidence for a Front Side Attack Mechanism. 94
Synthesis of new thiazinoindole derivatives and their evaluation as inhibitors of human leukocyte elastase and other related serine proteases 93
A method for determination of form and sizes of pocket in "receptor-ligand" complexes 93
The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development 92
Heterocyclic systems containing the pyrimido-2,4-dione ring as selective ligands for the alpha1-adrenoceptors 92
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin 92
How to choose the suitable template for homology modelling of GPCRs: 5-HT7 receptor as a test case 89
Conformational analysis and pharmacophore identification of new serotonin 5-HT4 receptor ligands made by DISCO 89
Building a model of interaction at the NK-2 receptors: Polycondensed heterocycles containing the pyrimidoindole skeleton 89
Potential of alkyl orthoformates as alkylating agents of non-electron rich nitrogen heterocycles 88
Structural data: the basis for molecular modelling 87
Synthesis and pharmacological activity of 6H-thiazolo[3’,2’:1,2]-5-oxopyrimido[5,4-b] Indole derivatives, a new heterocyclic ring system 87
Theoretical calculations of the catalytic triad in short chain alcohol dehydrogenases/reductases 86
Molecular modelling and site-directed mutagenesis reveal essential residues for 5-HT7 receptor binding 85
Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach 85
Peptidomimetics in Silico 85
Heme Oxygenase 1 and Heme Oxygenase 2 As Druggable Targets: Docking and Two Hybrid System To Identifying and Characterizing Protein-Proten Interactions. 84
Carbohydrate-Ligand Complex Binding: EMPIRICAL FREE ENERGY MODELING 84
Thiazole derivatives as inhibitors of purified bovine liver mitochondrial monoamine oxidase-B: structure-activity relationships and theoretical study 84
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies 83
Interactions of imidazoline ligands with the active site of purified monoamine oxidase A 82
Synthesis and pharmacological evaluation of pyrazolopyrimidobenzoxazole and pyrazolopyrimidobenzothiazole derivatives 82
Hydrophobic molecular similarity from MST fractional contributions to the octanol/water partition coefficient 81
Multi-conformational method of analysis of biological activity of molecular structures 81
Pyrazolothiazolopyrimidine derivatives as novel class of anti-inflammatory or antinociceptive agents: synthesis, structural characterization and pharmacological evaluation 80
Identification of an impurity in the synthesis of pharmacologically active pyrazolotriazolopyrimidines by a combined spectrometric approach 80
Docking simulation of complex between 2,5-xilidine and Rigidoporus lignosus laccase 80
Crystallographic, NMR and ab initio calculation studies of tautomerism among substituted thiazol-2-yl-hydrazines 80
COMBINING NMR AND MOLECULAR MODELLING IN A DRUG DELIVERY CONTEXT: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin 80
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases 79
MULTIGEN: A NEW PARADIGM FOR “MULTICONFORMATIONAL” ALIGNMENT OF MOLECULAR STRUCTURES IN 3D-QSAR STUDIES 79
Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors 78
Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis 78
Molecular modelling of a novel class of N5-methanesulfonamide dihydrothienopyrimidinoners as as potential dual COX-2 inhibitor/nitric oxide anti-releasing agents 78
DESIGN AND SYNTHESIS OF MULTIPLE LIGANS: NEW ARYLAMINES AND THEIR BINDING AFFINITY TOWARD 5-HT TRANSPORTER (SERT) AND 5-HT7- RECEPTORS 78
Potential of Pyrazolooxadiazinone Derivatives as Serine Protease Inhibitors 78
Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into alpha-, beta - and gamma -cyclodextrins 78
Evaluation of Imidazole-Based Compounds as Heme Oxygenase-1 Inhibitors 76
Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism 75
Potential of indole skeleton containing heterocycles as antagonists at the neurokinin (NK) receptor system 75
Synthesis and pharmacological properties of pyrazolotriazolopyrimidine derivatives 74
Comparing Log P Calculations by the Ghose-Crippen and Villar Methods 74
Receptor modeling using " Multiconformer" alignment: comparison of HASL and CoMFA in the analysis of 5-HT1A thienopyrimidinone ligands 74
How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling 74
Study on new neurokinin antagonists: polycondensed heterocycles containing the indole skeleton 74
STUDY OF STRUCTURAL AND DYNAMIC BEHAVIOUR OF IBUPROFEN AND ITS COMPLEXES WITH EUDRAGIT® RL100 BY NERANS OF SOLID STATE 74
Synthesis and COMFA study of new heterocyclic compounds as potential AcylCoA: cholesterol O-acyltransferase inhibitors 72
Emerging antifungal azoles and effects on Magnaporthe grisea 72
New heterocyclic ring systems. Synthesis and pharmacological activity of 6H-1,3,4-thiadiazolo [3’,2’: 1,2]-5-oxopyrimido[5,4-b]indole derivatives and of 1-phenyl-6H-1,2,4-Triazolo [1’,5’: 1,2]-5-oxopyrimido [5,4-b]Indole 72
PARM mapping of rat and human serotonin 1A (5-HT1A) receptor 70
Synthesis of 1-phenyl-6-arilsubstituted pyrazolopyrimidothiazole as antagonists at the NK-2 receptors 69
Study of structural and dynamic behaviour of ibuprofen and its complexes with Eudragit® RL100 by means of solid state NMR 69
Totale 9.712
Categoria #
all - tutte 41.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 0 147 40
2021/2022990 133 147 0 15 155 5 142 25 101 0 37 230
2022/20231.583 149 55 34 120 178 289 0 303 374 6 53 22
2023/2024511 39 67 23 39 25 81 3 12 2 15 134 71
2024/20252.693 14 468 133 156 495 351 104 129 241 266 140 196
2025/20265.124 287 190 980 377 885 991 712 109 240 312 41 0
Totale 12.865